Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-12-18 Sale | 2023-12-20 6:09 pm | POINT Biopharma Global Inc. | PNT | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N Former 10% Owner | 17,161,278 | $12.45 | $213,657,911 | 0 (Direct) | View |
| 2022-11-29 Purchase | 2022-11-30 7:56 pm | POINT Biopharma Global Inc. | PNT | MCCANN JOE A. Chief Executive Officer | 2,160 | $6.64 | $14,342 | 3,616,313 (Direct) | View |
| 2022-11-23 Purchase | 2022-11-28 4:03 pm | POINT Biopharma Global Inc. | PNT | Lubner David Charles Director | 3,600 | $6.85 | $24,660 | 3,600 (Direct) | View |
| 2022-11-25 Purchase | 2022-11-28 4:02 pm | POINT Biopharma Global Inc. | PNT | HOGUE GERALD L. Director | 3,660 | $6.815 | $24,943 | 3,660 (Direct) | View |
| 2022-11-28 Purchase | 2022-11-28 4:01 pm | POINT Biopharma Global Inc. | PNT | Malik Rajesh Director | 3,700 | $6.66 | $24,642 | 3,700 (Direct) | View |
| 2022-11-21 Purchase | 2022-11-23 12:43 pm | POINT Biopharma Global Inc. | PNT | MARGOLIN YAEL Director | 1,710 | $6.56 | $11,218 | 1,710 (Direct) | View |
| 2022-11-18 Purchase | 2022-11-21 5:54 pm | POINT Biopharma Global Inc. | PNT | GOODMAN JONATHAN R. Director | 6,000 | $6.33 | $37,980 | 41,872 (Indirect) | View |
| 2022-11-17 Purchase | 2022-11-21 5:52 pm | POINT Biopharma Global Inc. | PNT | SILBER ALLAN C Executive Chairman 10% Owner | 50,000 | $6.224 | $311,199 | 9,227,975 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-12-27 Disposition | 2023-12-27 5:41 pm | N/A 2026-12-01 | POINT Biopharma Global Inc. | PNT | GOODMAN JONATHAN R. Director | 131,235 | $0 | 0 (Direct) | View |
| 2023-12-26 Equity Swap | 2023-12-27 5:41 pm | N/A N/A | POINT Biopharma Global Inc. | PNT | GOODMAN JONATHAN R. Director | 41,872 | $0 | 0 (Indirect) | View |
| 2023-12-27 Disposition | 2023-12-27 5:40 pm | N/A 2026-11-03 | POINT Biopharma Global Inc. | PNT | KELLY JUSTYNA Chief Operating Officer | 278,152 | $0 | 0 (Direct) | View |
| 2023-12-27 Disposition | 2023-12-27 5:40 pm | N/A 2028-03-29 | POINT Biopharma Global Inc. | PNT | MCCANN JOE A. Chief Executive Officer | 1,074,438 | $0 | 0 (Direct) | View |
| 2023-12-22 Equity Swap | 2023-12-27 5:40 pm | N/A N/A | POINT Biopharma Global Inc. | PNT | MCCANN JOE A. Chief Executive Officer | 3,496,313 | $0 | 0 (Direct) | View |
| 2023-12-27 Disposition | 2023-12-27 5:39 pm | N/A 2026-07-20 | POINT Biopharma Global Inc. | PNT | JENSEN JESSICA D. EVP Clinical Development | 949,925 | $0 | 0 (Direct) | View |
| 2023-12-27 Disposition | 2023-12-27 5:39 pm | N/A 2027-07-06 | POINT Biopharma Global Inc. | PNT | FLESHNER NEIL E. Chief Medical Officer | 169,491 | $0 | 0 (Direct) | View |
| 2023-12-22 Equity Swap | 2023-12-27 5:39 pm | N/A N/A | POINT Biopharma Global Inc. | PNT | FLESHNER NEIL E. Chief Medical Officer | 3,006,574 | $0 | 0 (Direct) | View |
| 2023-12-27 Disposition | 2023-12-27 5:37 pm | N/A 2026-12-01 | POINT Biopharma Global Inc. | PNT | HOGUE GERALD L. Director | 113,299 | $0 | 0 (Direct) | View |
| 2023-12-26 Equity Swap | 2023-12-27 5:37 pm | N/A N/A | POINT Biopharma Global Inc. | PNT | HOGUE GERALD L. Director | 21,596 | $0 | 0 (Direct) | View |
| 2023-12-27 Disposition | 2023-12-27 5:37 pm | N/A 2027-07-06 | POINT Biopharma Global Inc. | PNT | Malik Rajesh Director | 95,363 | $0 | 0 (Direct) | View |
| 2023-12-26 Equity Swap | 2023-12-27 5:37 pm | N/A N/A | POINT Biopharma Global Inc. | PNT | Malik Rajesh Director | 3,700 | $0 | 0 (Direct) | View |
| 2023-12-27 Disposition | 2023-12-27 5:37 pm | N/A 2027-07-06 | POINT Biopharma Global Inc. | PNT | Lubner David Charles Director | 98,963 | $0 | 0 (Direct) | View |
| 2023-12-26 Equity Swap | 2023-12-27 5:37 pm | N/A N/A | POINT Biopharma Global Inc. | PNT | Lubner David Charles Director | 35,400 | $0 | 0 (Direct) | View |
| 2023-12-27 Disposition | 2023-12-27 5:36 pm | N/A 2026-08-17 | POINT Biopharma Global Inc. | PNT | DEMERS WILLIAM L. Chief Financial Officer | 432,844 | $0 | 0 (Direct) | View |
| 2023-12-27 Disposition | 2023-12-27 5:35 pm | N/A 2026-03-25 | POINT Biopharma Global Inc. | PNT | SILBER ALLAN C Executive Chairman | 876,585 | $0 | 0 (Direct) | View |
| 2023-12-22 Equity Swap | 2023-12-27 5:35 pm | N/A N/A | POINT Biopharma Global Inc. | PNT | SILBER ALLAN C Executive Chairman | 8,727,975 | $0 | 0 (Indirect) | View |
| 2023-12-27 Disposition | 2023-12-27 5:35 pm | N/A 2027-07-06 | POINT Biopharma Global Inc. | PNT | MARGOLIN YAEL Director | 97,073 | $0 | 0 (Direct) | View |
| 2023-11-06 Gift | 2023-11-07 6:33 pm | N/A N/A | POINT Biopharma Global Inc. | PNT | MCCANN JOE A. Chief Executive Officer | 120,000 | $0 | 3,496,313 (Indirect) | View |
| 2023-11-03 Gift | 2023-11-07 6:31 pm | N/A N/A | POINT Biopharma Global Inc. | PNT | SILBER ALLAN C Executive Chairman | 500,000 | $0 | 8,727,975 (Indirect) | View |
Ownership | 2023-11-06 3:35 pm | N/A N/A | POINT Biopharma Global Inc. | PNT | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N 10% Owner | 0 | $0 | 17,161,278 (Direct) | View |
| 2023-10-31 Gift | 2023-11-02 6:30 pm | N/A N/A | POINT Biopharma Global Inc. | PNT | FLESHNER NEIL E. Chief Medical Officer | 250,000 | $0 | 3,006,574 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-14 6:15 pm | N/A 2029-06-13 | POINT Biopharma Global Inc. | PNT | Martell Bridget A Director | 80,503 | $0 | 80,503 (Direct) | View |
| 2023-06-01 Option Award | 2023-06-05 5:36 pm | N/A 2029-06-01 | POINT Biopharma Global Inc. | PNT | HOGUE GERALD L. Director | 44,749 | $0 | 44,749 (Direct) | View |
| 2023-06-01 Option Award | 2023-06-05 5:36 pm | N/A 2029-06-01 | POINT Biopharma Global Inc. | PNT | GOODMAN JONATHAN R. Director | 44,749 | $0 | 44,749 (Direct) | View |
| 2023-06-01 Option Award | 2023-06-05 5:35 pm | N/A 2029-06-01 | POINT Biopharma Global Inc. | PNT | MARGOLIN YAEL Director | 44,749 | $0 | 44,749 (Direct) | View |
| 2023-06-01 Option Award | 2023-06-05 5:35 pm | N/A 2029-06-01 | POINT Biopharma Global Inc. | PNT | Malik Rajesh Director | 44,749 | $0 | 44,749 (Direct) | View |
| 2023-06-01 Option Award | 2023-06-05 5:35 pm | N/A 2029-06-01 | POINT Biopharma Global Inc. | PNT | Lubner David Charles Director | 44,749 | $0 | 44,749 (Direct) | View |
| 2023-03-28 Option Award | 2023-03-30 8:16 pm | N/A 2029-03-28 | POINT Biopharma Global Inc. | PNT | SILBER ALLAN C Executive Chairman 10% Owner | 537,322 | $0 | 537,322 (Direct) | View |
| 2023-03-28 Option Award | 2023-03-30 8:12 pm | N/A 2029-03-28 | POINT Biopharma Global Inc. | PNT | MCCANN JOE A. Chief Executive Officer | 692,643 | $0 | 692,643 (Direct) | View |
| 2023-03-28 Option Award | 2023-03-30 8:11 pm | N/A 2029-03-28 | POINT Biopharma Global Inc. | PNT | KELLY JUSTYNA Chief Operating Officer | 98,358 | $0 | 98,358 (Direct) | View |
| 2023-03-28 Option Award | 2023-03-30 8:08 pm | N/A 2029-03-28 | POINT Biopharma Global Inc. | PNT | JENSEN JESSICA D. EVP Clinical Development | 136,055 | $0 | 136,055 (Direct) | View |
| 2023-03-28 Option Award | 2023-03-30 8:07 pm | N/A 2029-03-28 | POINT Biopharma Global Inc. | PNT | FLESHNER NEIL E. Chief Medical Officer | 84,257 | $0 | 84,257 (Direct) | View |
| 2023-03-28 Option Award | 2023-03-30 8:04 pm | N/A 2029-03-28 | POINT Biopharma Global Inc. | PNT | DEMERS WILLIAM L. Chief Financial Officer | 131,355 | $0 | 131,355 (Direct) | View |
| 2023-03-21 Exercise | 2023-03-23 8:09 pm | N/A N/A | POINT Biopharma Global Inc. | PNT | HOGUE GERALD L. Director | 17,936 | $6.97 | 39,532 (Direct) | View |
| 2023-03-21 Exercise | 2023-03-23 8:09 pm | N/A 2026-12-01 | POINT Biopharma Global Inc. | PNT | HOGUE GERALD L. Director | 17,936 | $0 | 39,532 (Direct) | View |
| 2022-06-02 Option Award | 2022-06-06 4:05 pm | N/A 2028-06-02 | POINT Biopharma Global Inc. | PNT | GOODMAN JONATHAN R. Director | 25,614 | $0 | 25,614 (Direct) | View |
| 2022-06-02 Option Award | 2022-06-06 4:05 pm | N/A 2028-06-02 | POINT Biopharma Global Inc. | PNT | HOGUE GERALD L. Director | 25,614 | $0 | 25,614 (Direct) | View |
| 2022-06-02 Option Award | 2022-06-06 4:04 pm | N/A 2028-06-02 | POINT Biopharma Global Inc. | PNT | Lubner David Charles Director | 25,614 | $0 | 25,614 (Direct) | View |